G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis

Status Completed

Clinical Trial Summary

The logistic advantages and advanced training capabilities of the G-EO System, as well as the benefits reported in other populations, support this strategy as a potentially potent rehabilitation tool for restoring and maintaining function in progressive Multiple Sclerosis (MS). This approach represents a paradigm shifting opportunity for improving current clinical practices for patients with progressive MS. If successful, this project will provide initial evidence for increasing patient access to the G-EO System, and this could be accomplished through "regional technology centers" using a rural health-delivery approach. There are several novel aspects of the proposed trial: (1) the examination of a novel gait rehabilitation stimulus (G-EO System) that could alter current clinical practices; (2) the focus on patients with progressive MS who have gait impairment (i.e., those who have received minimal research attention), which was recently described as the greatest therapeutic challenge facing the MS community; and (3) a study design that accounts for standard therapy. Specific Aims: The investigators designed a single-blinded, randomized pilot trial of electromechanically-assisted gait training using the G-EO System in patients with progressive MS with gait disability (EDSS=4.0-7.5). Specific Aim 1 will establish the safety and feasibility of gait training using the G-EO System. Specific Aim 2 will determine the efficacy of gait training using the G-EO System for improving mobility, symptomatic, quality of life, and participatory outcomes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Multiple Sclerosis
Multiple Sclerosis, Chronic Progressive
Progressive Multiple Sclerosis
Sclerosis

Clinical Trial Details

NCT number	NCT03980145
Study type	Interventional
Source	Indiana University
Contact
Status	Completed
Phase	N/A
Start date	May 2, 2017
Completion date	March 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02282826` - A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis	Phase 1
Completed	`NCT02804594` - A Study of Oxidative Pathways in MS Fatigue	Phase 2
Completed	`NCT04120675` - Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis	N/A
Completed	`NCT01719159` - Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis	Phase 2
Enrolling by invitation	`NCT03552211` - Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis
Recruiting	`NCT05740722` - Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis	Phase 2
Completed	`NCT03269071` - Neural Stem Cell Transplantation in Multiple Sclerosis Patients	Phase 1
Not yet recruiting	`NCT05811013` - Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis	N/A
Not yet recruiting	`NCT04289909` - Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)	N/A
Recruiting	`NCT05685784` - Multiple Sclerosis Prediction and Monitoring of Progression Study	N/A
Completed	`NCT03493841` - Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis	Phase 1
Completed	`NCT03302806` - Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis
Recruiting	`NCT05441488` - Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis	Phase 3
Recruiting	`NCT04695080` - ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis	Phase 2/Phase 3
Completed	`NCT03423121` - A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis	Phase 1/Phase 2
Terminated	`NCT02580669` - Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis	N/A
Enrolling by invitation	`NCT05706220` - Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
Recruiting	`NCT01815632` - Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)	Phase 2
Recruiting	`NCT01364246` - Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica	Phase 1/Phase 2
Recruiting	`NCT05937802` - Osmotin Plant Protein for Progressive Multiple Sclerosis	N/A